Vanda Pharmaceuticals seeks FDA nod for breakthrough psoriasis drug
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
Subscribe To Our Newsletter & Stay Updated